A Landscape Analysis of Oncolytic Virus Therapies & Combination Therapies
Time: 3:30 pm
day: Day One
Details:
• Exploring the preclinical landscape of oncolytic virotherapies, highlighting key developers
• Analysing the clinical landscape, highlighting key combination therapies used in trials and the relevant drug developers
• Outlining key regulatory announcements or deals, especially for combination trials, and examining the future outlook of the oncolytic virus field
